S2312: A Phase III Study of Cabazitaxel with or without Carboplatin in Patients with Metastatic Castrate Resistant Prostate Cancer (MCRPC), Stratified by Aggressive Variant Signature
- Title
- A Phase III Study of Cabazitaxel with or without Carboplatin in Patients with Metastatic Castrate Resistant Prostate Cancer (MCRPC), Stratified by Aggressive Variant Signature
- Principal Investigator
- Kolodney, Joanna
- Phase
- III
- Age Group
- Adult
- Applicable Disease Sites
- Genitourinary Cancers
- Participating Institutions
- Mary Babb Randolph Cancer Center
- Contacts
- Jill Stone, LPN
- Research Specialist
- Phone: +1 304-634-4417
- Email: jill.stone@hsc.wvu.edu
- Patricia Policicchio
- Research Specialist
- Email: patricia.policicchio@hsc.wvu.edu